Novel antibody engineered product to treat COVID-19 cleared for clinical trials thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Express News Service
HYDERABAD: An in-vitro study by researchers of University of Hyderabad, Centre for Cellular and Molecular Biology and a startup incubated at UoH - VINS Bio Products Limited, has shown that antibody fragments derived from horses might prove an effective therapy against Covid-19.
The study also indicates the therapy might work against the emerging variants of coronavirus as well.
A pre-print research paper on the study’s findings, ‘Development of Equine Immunoglobulin Fragment F(ab’)2 with High Neutralizing 2 Capability against SARS-CoV-2’, was recently uploaded on medrxiv.com.
In layman’s terms, the method involves immunisation of horse with inactivated novel coronavirus.